Lorena Jauregui-Covarrubias, MD
Family Medicine · Yuma, AZNPI 1861442741
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $490,570 of the $490,927 with a category attached, or 99.9%. CSL Plasma Inc. accounts for 72.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $136,217, more than ten times the $13 reported in 2019. Among family medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $1825.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$356K
- CSL Behring$134K
- Abbott$170
- AbbVie$119
- Lilly USA, LLC$22
- Bayer$19
- plus $27 from 2 others
What the payments were for
- Consulting fees$490,570100%
- Food & beverage$3570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Plasma Inc. | 170 | $356,310 |
| CSL Behring | 87 | $134,260 |
| Abbott | 2 | $170 |
| AbbVie | 6 | $119 |
| Lilly USA, LLC | 1 | $22 |
| Bayer | 1 | $19 |
| Novo Nordisk | 1 | $14 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$490,927 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 41 | $65,264 |
| OzempicSemaglutide | 37 | $44,172 |
| EliquisApixaban | 36 | $39,828 |
| JardianceEmpagliflozin | 20 | $31,488 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $18,330 |
| TradjentaLinagliptin | 11 | $15,791 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $3,797 |
| Atorvastatin Calcium | 203 | $2,791 |
| Losartan Potassium | 169 | $2,364 |
| Levothyroxine Sodium | 172 | $2,180 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 33 | $1,964 |
| Nebivolol Hcl | 27 | $1,873 |
| Nifedipine ErNifedipine | 39 | $1,723 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $1,326 |
| Tamsulosin Hcl | 69 | $1,289 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $22 | $65,26441 claims |
| Novo NordiskOzempic | $14 | $44,17237 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Yuma
- Ryan CaseyYuma$231K
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
- Heather ElwoodPhoenix$236K
- Suzanne BentzMesa$174K
- Brent AllanParadise Valley$108K
- Ahmed AghaPhoenix$92K
- Valerie MirandaPhoenix$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.